[1] 宋丽.NSCLC患者T淋巴细胞亚群的分布及临床意义[D].苏州:苏州大学,2012:1-18. [2] 张瑞萍,徐冰心,郑成中,等.非小细胞肺癌外周血淋巴细胞亚群及Treg细胞水平变化观察[J].人民军医,2013,56(7):808-810. [3] 崇杨,江涛,张冬华,等.射频消融术对原发性肝癌患者甲胎蛋白和外周血CD4+CD25+Foxp3+Treg细胞的影响[J].江苏大学学报:医学版,2013,23(2):177-179. [4] Marshall EA,NG KW,Kung SH,et al. Emerging roles of T helper 17 and T cells in lung cancer progression and metastasis[J]. Mol Cancer,2016,15(1):67-69. [5] Akhtari M,Bernicker EH,Teh BS. Chemotherapy in non-small cell lung cancer:opportunities for advancement[J]. Chin J Cancer,2016,35(1):56. [6] 彭艳梅,崔慧娟,徐央波,等.2005-2014年中日友好医院肺癌发病情况研究[J].中国全科医学,2016,5:565-569. [7] 涂庆,王宇,黄莉. PM2.5与肺癌相关关系及防治策略研究[J].重庆医学,2016,45(8):1118-1121. [8] 刘韫宁,齐金蕾,刘江美,等.1990年与2013年中国人群肺癌疾病负担分析[J].中华流行病学杂志,2016,37(6):752-757. [9] Banat GA,Tretyn A,Pullamsetti SS,et al. Immune and Inflammatory cell composition of human lung caner stroma[J]. Plos One,2015,10(9):9013-9073. [10] Kurose K,Ohue Y,Wada H,et al. Phase in study of FoxP3+ CD4 Treg depletion by infusion of a humanized Anti-CCR4 antibody,KW-0761,in cancer patients[J]. Clin Cancer Res,2015,21(19):4327-4336. [11] Nishikawa H,Sakaguchi S. Regulatory T cells in cancer immunotherapy[J]. Curr Opin Immunol,2014,27(1):1-7. [12] Peguillet I,Milder M,Louis D,et al. High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer[J].Cancer Res,2014,74(8):2204-2216. [13] 殷红梅,王磊,胡晓波,等.非小细胞肺癌患者外周血CD4+T淋巴细胞亚群的变化及临床意义[J]. 检验医学与临床,2017,14(6):759-761. [14] 袁嘉敏,余齐鸣,凌志强.胃癌外周血淋巴细胞亚群表达水平对患者生存率的影响[J].中华胃肠外科杂志,2011,14(10):796-798. [15] 罗君,凌志强,毛伟敏.肺癌患者淋巴细胞亚群在外周血中的表达及其与预后的关系[J].中国肺癌杂志,2011,14(8):699-673. [16] Maruyama T,Konkd JE,Zamatron BF,et al. the molecular mechanisms of Foxp3 gene regulation[J]. Semin Immunol,2011,23(6):418-423. [17] Li Q,Bao JM,Zhang T,et al. Inhibiting effect of astragalus poly-saccharides on the functions of CD4+CD25+ high Treg cells in the tumor microenvironment of human hepatocellular carcinoma[J]. Clin Med(Engl),2012,125(5):786-793. [18] 付白清,吴朝阳,许亚平,等.食管癌患者外周血CD4+CD25+Foxp3+调节性T细胞检测及其临床意义[J].江苏大学学报:医学版,2008,18(6):532-534. [19] 于荣,侯建青.紫杉醇联合铂类化疗对晚期卵巢上皮细胞癌患者CD4+CD25+Foxp3+细胞的影响及意义[J].滨州医学院学报,2012,35(4):248-250. [20] 焦志军,尤海燕,陈蕾,等.流式细胞术检测表达Foxp3的CD4+CD25+调节性T细胞[J].临床检验杂志,2008,126(13):161-163.
